Pharmacological Treatment Disruption in Women With Post-Partum Depression (PPD) During COVID-19: A Retrospective Cohort Study Using Claim Data

Author(s)

Paul K1, Verma V2, Sharma A1, Roy A1, Pandey S1, Kukreja I1, Daral S1, Nayyar A1, Gaur A1, Chopra A1, Anand S1, Gupta A1
1Optum, Gurugram, HR, India, 2Optum, Gurgaon, HR, India

OBJECTIVES: Postpartum depression (PPD) has been described as “the thief that steals motherhood” by depriving women of the anticipated joy of a new infant. Through this study, we intend to see the incidence, treatment rates (TR), relative-treatment rate (TRR), absolute treatment rate (ATR), and number needed to treat (NNT) pre- and post-COVID-19 on treatment of women with PPD.

METHODS:

This retrospective cohort study included newly diagnosed patients with PPD in 2019 (1st Jan – 31st Dec [pre-pandemic]) and 2020 (1st Jan – 31st Dec [pandemic]) using ICD-10-CM codes from Optum’s de-identified Clinformatics Data Mart. Only the patients having continuous eligibility between 12 months before (baseline period) to 12-months post (follow-up period) the first diagnosis of PPD (index date) were included in study. During the follow-up period, patients were then checked for pharmacological treatment received (SSRI, SNRI’s and other anti-depressants) using NDC codes. To measure effects, percentages of patients getting treatment, TRR (TR in pandemic/TR in pre-pandemic), ATR (TR in pre-pandemic - TR in a pandemic), and NNT (1/ATR) were calculated before and during COVID. The significance of categorical variables was examined using the Chi-square test.

RESULTS:

We observed 39% increase in incidence of PPD patients during pandemic (n=16,095) vs pre-pandemic (n=11,565). Only 51% TR (risk ratio) was observed during pandemic vs 60% TR (risk ratio) in pre-pandemic with any SSRI, SNRI, and anti-depressants (p<.01). Compared to patients receiving treatment during pandemic vs pre-pandemic: TRR was found to be 85% (relative risk) and ATR was 9% (absolute risk reduction). The NNT comparing pre- and during pandemic was 11.

CONCLUSIONS:

The results of the study demonstrated that treatment of women with PPD was impacted during pandemic vs pre-pandemic (9% women did not receive treatment during pandemic). Alternative methods or non-pharmacological treatments may be required to further alleviate non-treated patients and improve their condition.

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

RWD161

Topic

Study Approaches

Topic Subcategory

Meta-Analysis & Indirect Comparisons

Disease

SDC: Mental Health (including addiction)

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×